Table 2 Baseline vital parameters and laboratory results of 13 HIV-positive participants and 12 HIV-positive persons of the Reference group
Parameter | Participants (Baseline) | Reference Group | p (Participants vs. Reference group) |
|---|---|---|---|
CD4-count (/μl) | 620 [146–1268] | 571 [230–955] | 0.81 |
Annexin-binding (% of CD4+ cells) | 53 [47–64] | 51 [46–52] | 0.12 |
Sodium (mmol/l) | 139 [136–142] | 139 [132–141] | 0.58 |
Phosphate (mmol/l) | 1.06 [0.86–1.20] | 0.91 [0.66–1.19] | 0.03 |
Weight (kg) | 78 [58–100] | 77 [59–88] | 0.44 |
Height (cm) | 174 [158–182] | 179 [168–185] | |
RRsys (mmHg) | 125 [100–145] | 115 [100–130] | 0.06 |
RRdia (mmHg) | 80 [70–90] | 70 [60–90] | 0.08 |
Leukocytes (G/l) | 6.1 [4.1–9.5] | 6.3 [3.8–10.6] | 0.80 |
Hemoglobin (g/dl) | 15.9 [11.3–17.3] | 14.6 [12.9–16.2] | 0.38 |
Thrombocytes (G/l) | 225 [171–294] | 255 [147–342] | 0.50 |
INR | 1 [0.9–1.2] | 1 [0.9–1.1] | 0.06 |
Potassium (mmol/l) | 3.9 [3.6–4.5] | 4.3 [4.0–4.9] | 0.001 |
Creatinine (mg/dl) | 1.05 [0.8–1.17] | 0.96 [0.74–1.16] | 0.31 |
Triglycerides (mg/dl) | 156 [85–328] | 141 [67–326] | 0.95 |
Cholesterol (mg/dl) | 185 [98–250] | 177 [111–302] | 0.98 |
HDL-cholesterol (mg/dl) | 48 [31–60] | 40 [28–54] | 0.28 |
LDL-cholesterol (mg/dl) | 115 [45–161] | 111 [61–198] | 0.81 |
Insulin (mIU/l) | 4.4 [2.1–9.5] | 6 [2–35] | 0.15 |
Glucose (mg/dl) | 86 [78–107] | 91 [83–100] | 0.17 |
Bilirubin (mg/dl) | 0.56 [0.28–2.90] | 0.47 [0.26–2.90] | 0.70 |
ALT (U/l) | 25 [10–126] | 23 [10–53] | 0.42 |
Creatine kinase (U/l) | 105 [66–145] | 86 [55–155] | 0.64 |